Loading...

Fresh2 Group Limited

FRESNASDAQ
Healthcare
Biotechnology
$0.85
$-0.26(-23.42%)

Fresh2 Group Limited (FRES) Stock Overview

Explore Fresh2 Group Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.2/100

Key Financials

Market Cap2.1M
P/E Ratio-0.00
EPS (TTM)$-72.06
ROE11.22%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.52

FRES Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Fresh2 Group Limited (FRES) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 2.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;